{"id":"W114597356","doi":"10.1182/blood.v122.21.408.408","title":"Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Internal medicine; Tolerability; Clinical endpoint; Dexamethasone; Neutropenia; Phases of clinical research; Population; Bortezomib; Ixazomib; Oncology; Multiple myeloma; Surgery; Adverse effect; Randomized controlled trial; Clinical trial; Toxicity; Carfilzomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685828,0.001073943,0.001700076,0.0004056917,0.0003980457,0.0008494994,0.0009710075,0.0009520325,0.004683905],"category_scores_gemma":[0.0007526155,0.0005903842,0.002377517,0.0004277843,0.0007076204,0.000536329,0.0003932898,0.002944998,0.0005741135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00122091,"about_ca_system_score_gemma":0.001263044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001187509,"about_ca_topic_score_gemma":0.002993518,"domain_scores_codex":[0.9996129,0.0001696919,0.00002895311,0.00006967887,0.00004438966,0.00007443724],"domain_scores_gemma":[0.9993742,0.0001076924,0.0001455154,0.00004570866,0.00003908055,0.0002878341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9182986,0.02653004,0.005013012,0.0004320653,0.001293763,0.0001186729,0.0001138861,0.001156918,0.01578049,0.0001465051,0.001491419,0.02962462],"study_design_scores_gemma":[0.410607,0.5616715,0.01904958,0.00004803075,0.001417265,0.0002116159,0.00005528211,0.0008868559,0.003758895,0.0002624761,0.001998783,0.00003276075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938633,0.001666736,0.0002500257,0.0002022004,0.000073812,0.001446419,0.001413814,0.00005385287,0.001029905],"genre_scores_gemma":[0.9926264,0.0008727828,0.0007547402,0.000382379,0.0000763852,0.001729689,0.001426599,0.00001754684,0.002113523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004683905,"threshold_uncertainty_score":0.01566923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05765599266490275,"score_gpt":0.3362586634539979,"score_spread":0.2786026707890951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}